Hypertension in pregnancy

Current Hypertension Reports

Volumn 7, Issue 5, 2005, Pages 348-354

  Mugo, Maryann ^a   Govindarajan, Gurushankar ^a   Kurukulasuriya, L Romayne ^a   Sowers, James R ^a   McFarlane, Samy I ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FELODIPINE; FUROSEMIDE; HYDRALAZINE; LABETALOL; MAGNESIUM SULFATE; METHYLDOPA; NIFEDIPINE; NITROPRUSSIDE SODIUM; PHENYTOIN; PLACEBO; PLACENTAL GROWTH FACTOR; PROSTACYCLIN; RENIN; SUXAMETHONIUM; THIAZIDE DIURETIC AGENT; THROMBOXANE A2; UNINDEXED DRUG; VASCULOTROPIN RECEPTOR 1; VASODILATOR AGENT;

ABDOMINAL RADIOGRAPHY; ANTICONVULSANT ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BRADYCARDIA; CLINICAL FEATURE; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG SAFETY; ECHOGRAPHY; ECLAMPSIA; ENDOMETRIAL DISEASE; FEMALE; FETOTOXICITY; GESTATION PERIOD; HELLP SYNDROME; HIGH RISK PREGNANCY; HUMAN; INTRACTABLE EPILEPSY; LABORATORY TEST; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; MATERNAL MORTALITY; META ANALYSIS; MULTIPLE ORGAN FAILURE; NEWBORN MORBIDITY; NEWBORN MORTALITY; NON INVASIVE MEASUREMENT; PATHOPHYSIOLOGY; PATIENT MONITORING; PLACENTA INSUFFICIENCY; PLACENTA PERFUSION; PLASMA RENIN ACTIVITY; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY TERMINATION; PREMATURITY; PREVALENCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMALL FOR DATE INFANT; SYSTOLIC BLOOD PRESSURE;

EID: 27544469107     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-005-0068-2     Document Type: Review

References (54)

1. Roberts J, Pearson G, Cutler J, Lindheimer M: Summary of the NHLBI Working Group on Research on Hypertension during Pregnancy. Hypertension 2003, 41:437-445.
2. Gifford RW, August PA, Cunningham G, et al.: Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000, 183:S1-S22.
3. Montan S: Drugs used in hypertensive diseases in pregnancy. Current Opin Obstet Gynecol 2004, 16:111-115.
4. Sibai B: Chronic hypertension in pregnancy. Obstet Gynecol 2002, 100:369-377.
5. Burt VL, Whetton P, Rochella EJ, et al.: Prevalence of hypertension in the US adult population: results from the third national health and nutrition examination survey, 1988-1991. Hypertension 1995, 25:305-313.
6. Sibai BM, Villar MA, Mabie BC: Acute renal failure in hypertensive disorders of pregnancy: pregnancy outcome and remote prognosis in thirty-one consecutive cases. AmJ Obstet Gynecol 1990, 162:777-783.
7. Sibai BM, Lindheimer M, Hauth J, et al.: Risk factors for preeclampsia, abruption placentae, and adverse neonatal outcomes among women with chronic hypertension. N Engl J Med 1998, 339:667-671.
8. Ferrer RL, Sibai BM, Murlow CD, et al.: Management of mild chronic hypertension during pregnancy: a review. Obstet Gynecol 2000, 96:849-860.
9. August P, Helseth G, Cook F, et al.: A prediction model for superimposed preeclampsia in women with chronic hypertension during pregnancy. Am J Obstet Gynecol 2004, 191:1666-1672.
10. Chelsey LC: Hypertensive Disorders of Pregnancy. New York, NY: Appleton-Century-Crofts: 1978.
11. Sibai B: Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003, 102:181-192.
12. Kaplan NM: Hypertension with pregnancy and the pill. In Kaplan's Clinical Hypertension. Edited by Kaplan NM. Philadelphia: Lippincott Williams & Wilkins; 1994:343-365.
13. Dekker G, Sibai B: Pathogenesis and etiology of preeclampsia. Am J Obstet Gynecol 1998, 179:1359.
14. Levine RJ, Maynard SE, Qian C, et al.: Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004, 350:672-683.
15. Roberts JM: Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998, 16:5-15.
16. Gonzalez-Quintero VH, Smakursky LP, Jiminez JJ, et al.: Elevated plasma endothelial microparticles: preeclampsia versus gestational hypertension. Am J Obstet Gynecol 2004, 191:1418-1424.
17. Roberts JM, Hubel CA: Is oxidative stress the link in the two-stage model of pre-eclampsia? (letter) Lancet 1999, 354:788-789.
18. Roberts JM, Hubel CA: Oxidative stress in preeclampsia. Am J Obstet Gynecol 2004, 190:1177-1178.
19. Sibai B, El-Nazer A, Gonzalez-Ruiz A: Severe preeclampsia-eclampsia in young primigravid women: subsequent outcome and remote prognosis. Am J Obstet Gynecol 1986, 155:1011-1016.
20. Hubel C, Roberts J: Lipid metabolism and oxidative stress. In Chesley's Hypertensive Disorders in Pregnancy. Edited by Lindheimer M, Roberts J, Cunningham F. Stamford, CT: Appleton & Lange; 1999:453-486.
21. Redman CW, Sacks GP, Sargent IL: Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999, 180:499-506.
22. Dekker G, Sibai B: Primary, secondary, and tertiary prevention of preeclampsia. Lancet 2001, 357:209-215.
23. Kinzler W, Smulian J, Ananth C, et al.: Noninvasive ultrasound measurement of maternal vascular reactivity during pregnancy. a longitudinal study. Obstet Gynecol 2004, 104:362-366.
24. Levine R, Thadhani R, Qian C, et al.: Urinary placental growth factor and risk of preeclampsia. JAMA 2005, 293:77-85.
25. Cockburn J, Moar VA, Ounsted M, Redman CW: Final report of the study on hypertension during pregnancy, the effects of specific treatment on the growth and development of the children. Lancet 1982, 1:647-649.
26. Barrilleaux P, Marin J: Hypertension therapy during pregnancy. Clinical Obstet Gynecol 2002, 45:22-24.
27. Magee LA, Duley L: Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2003, 3:CD002863.
28. Rubin PC, Butters L, Clark DM, et al.: Placebo controlled trial of atenolol in pregnancy-associated hypertension. Lancet 1983,I:431-434.
29. Easterling TR, Carr B, Brateng DB, et al.: Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery and fetal growth. Obstet Gynecol 2001, 98:427-433.
30. Reynolds B, Butters L, Evans J, et al.: First year of life after use of atenolol in pregnancy. Arch Dis Child 1984, 59:1061-1063.
31. El-Qarmalawi AM, Morsy AH, al-Fadly A, et al.: Labetalol vs. methyldopa in the treatment of pregnancy-induced hypertension. Int J Gynaecol Obstet 1995, 49:125-130.
32. MacPherson M, Pipkin FB, Rutter N, et al.: The effect of maternal labetalol on the newborn infant. Br J Obstet Gynaecol 1986, 93:539-542.
33. Constantine G, Beevers D, Reynolds A, et al.: Nifedipine as a second line antihypertensive drug in pregnancy. Br J Obstet Gynecol 1987, 94:1136-1142.
34. Bortolus R, Ricci E, Chatenoud L, et al.: Nifedipine administered in pregnancy. Effect on development of children at 18 months. BJOG 2000, 107:792-794.
35. Fenakel K, Fenakel G, Appelman Z, et al.: Nifedipine in the treatment of severe pre-eclampsia. Obstet Gynecol 1991, 77:331-337.
36. Stempel J, O'Grady J, Morton M, et al.: Use of sodium nitroprusside in complications of gestational hypertension. Obstet Gynecol 1982, 60:533-538.
37. Collins R, Yusuf S, Peto R: Overview of randomized trials of diuretics in pregnancy. Br Med J 1985, 290:17-23.
38. Arias F, Zamora J: Antihypertensive treatment and pregnancy outcome in patients with mild chronic hypertension. Obstet Gynecol 1979, 53:489-494.
39. Chung N, Beevers A, Gareth D, et al.: Management of hypertension in pregnancy. Am J Cardiovasc Drugs 2001, 1:253-262.
40. Sedman A, Kershaw DB, Buncjman TE: Recognition and management of angiotensin converting enzyme inhibitor fetopathy. Pediatr Nephrol 1995, 9:382-385.
41. Burrows RF, Burrows EA: Assessing the teratogenic potential of angiotensin converting enzyme inhibitors in pregnancy. Aust N Z J Obstet Gynecol 1998, 38:306-311.
42. Lip GY, Churchill D, Beevers M, et al.: Angiotensin-converting-enzyme inhibitors in early pregnancy. Lancet 1997, 350:1446-1447.
43. Chung N, Lip GY, Beevers M, et al.: Angiotensin II converting enzyme inhibitors in pregnancy. Lancet 2001, 357:1620.
44. Churchill D, Beevers DG: Hypertension in Pregnancy. London: BMJ Books; 1999.
45. Duley L, Henderson-Smart D: Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Syst Rev 2003, 4:CD000128.
46. Griffis KR, Martin JN, Palmer SM, et al.: Utilization of hydralazine or methyldopa for the management of early puerperal hypertension. Am J Perinatol 1989, 6:437-441.
47. Sibai BM, Mercer B, Saringlu C, et al.: Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol 1991, 165:140.
48. Atallah AN, Holmeyr GJ, Duley L: Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 2002, 1:CD001059.
49. Duley L, Henderson-Smart D, Knight M, et al.: Antiplatelet drugs for prevention of preeclampsia and its consequences. BMJ 2001, 322:329-333.
50. Vainio M, Riutta A, Koivisto AM, et al.: Prostacyclin, thromboxane A and the effect of low dose aspirin in pregnancies at high risk of hypertensive disorders. Act Obstet Gynecol Scand 2004, 83:1119-1123.
51. Sibai BM, Taslimi MM, El-Nazer A, et al.: Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986, 155:501-509.
52. Sibai BM: Diagnosis controversies and management of the syndrome of hemolysis, elevated liver enzymes and low platelet count. Obstet Gynecol 2004, 103:981-991.
53. Audibert F, Friedman SA, Frangieh AY, et al.: Clinical utility of strict diagnostic criteria for the HELLP syndrome. Am J Obstet Gynecol 1996, 175:460-464.
54. Abramovici D, Friedman SA, Mercer BM, et al.: Neonatal outcome in severe preeclampsia at 24 to 36 weeks gestation: Does HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter? Am J Obstet Gynecol 1999, 180:221-225.